Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
In the latest session, Dermata Therapeutics Inc (NASDAQ: DRMA) closed at $1.17 down -1.68% from its previous closing price of $1.19. In other words, the price has decreased by -$1.68 from its previous closing price. On the day, 5.29 million shares were traded. DRMA stock price reached its highest trading level at $1.65 during the session, while it also had its lowest trading level at $1.07.
Ratios:
For a deeper understanding of Dermata Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.44 and its Current Ratio is at 3.44. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DRMA now has a Market Capitalization of 2387700 and an Enterprise Value of -3382398.
Stock Price History:
The Beta on a monthly basis for DRMA is 0.66, which has changed by -0.8381743 over the last 52 weeks, in comparison to a change of 0.23809385 over the same period for the S&P500. Over the past 52 weeks, DRMA has reached a high of $8.65, while it has fallen to a 52-week low of $1.00. The 50-Day Moving Average of the stock is -5.24%, while the 200-Day Moving Average is calculated to be -49.81%.
Shares Statistics:
For the past three months, DRMA has traded an average of 375.01K shares per day and 1123110 over the past ten days. A total of 2.04M shares are outstanding, with a floating share count of 2.02M. Insiders hold about 0.84% of the company’s shares, while institutions hold 0.32% stake in the company. Shares short for DRMA as of 1730332800 were 93737 with a Short Ratio of 0.38, compared to 1727654400 on 69108. Therefore, it implies a Short% of Shares Outstanding of 93737 and a Short% of Float of 6.280000500000001.
